General Cardiovascular Risk Assessment Scores

SCORE2-OP Calculator

Clinical calculation support · Verify results before clinical use

Patient risk factors

European cardiovascular risk assessment for older adults. All fields are required.

70–89
Years

Awaiting patient data

Complete all inputs to calculate the 10-year cardiovascular risk.

This calculator applies the original 2021 SCORE2-OP model and European regional recalibration.

About the model

SCORE2-OP estimates 10-year risk of fatal or nonfatal cardiovascular disease (cardiovascular death, myocardial infarction, or stroke) in older adults without known atherosclerotic cardiovascular disease. It accounts for competing non-cardiovascular mortality and uses sex-specific coefficients and European regional recalibration.

Interpretation

Age group	Lower risk	High risk	Very high risk
≥70 years	<7.5%	7.5% to <15%	≥15%

These are 2021 ESC prevention guideline age-specific 10-year risk categories, not automatic treatment mandates. Consider frailty, life expectancy, comorbidities, treatment preferences, and clinical context.

Model limitations

Not intended for patients with established ASCVD. The European region-specific model has not been validated for routine application to Indonesian populations. A 10-year estimate may be less meaningful in patients with limited life expectancy. The model is not a diagnostic test.

Scientific references

SCORE2-OP working group and ESC Cardiovascular risk collaboration. SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions. European Heart Journal. 2021;42:2455–2467. doi:10.1093/eurheartj/ehab312.

Visseren FLJ, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. European Heart Journal. 2021. doi:10.1093/eurheartj/ehab484.

Clinical disclaimer: This risk prediction tool supports clinical assessment and shared decision-making. It does not replace professional judgment or establish treatment eligibility on its own. Check geographic applicability before clinical use.